NCT04334031Recruiting
Deployment o the Multidisciplinary Prospective Cohort Imminent
Source: ClinicalTrials.gov · Last updated 5 May 2026
Brief summary (registry, in English)
Immune-mediated inflammatory diseases (IMIDs) most often affect young patients and have high impact on morbidity and mortality with a significant alteration in the quality of life of patients with professional, social and emotional repercussions. Beyond this burden, IMIDs share many common pathophysiological mechanisms and treatments, known as "targeted therapies". Despite progress in this field, much remains to be done in clinical, therapeutic and fundamental research to address the efficacy, resistance and side-effects of treatment. These similarities between IMIDs have led the FHU IMMINeNT to propose the creation of a prospective, multidisciplinary clinical-biological database (IMMINeNT cohort), associated to a biobank, of patients with IMIDs. The main objectives of this database will be to identify new prognostic and therapeutic biomarkers in order to develop new therapeutic targets and biomarkers, to identify prognostic factors and determinants related to the activity, severity and quality of life of patients with IMIDs as well as to the response and tolerance to treatment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 2200 (estimated)
- First submitted
- 10 Mar 2020
- Start date
- 20 Jul 2020
- Primary completion date
- 20 Jul 2031
- Lead sponsor
- University Hospital, Lille
- Diseases
- Atopic dermatitis (eczema), Psoriasis, Systemic sclerosis (scleroderma), Asthma, Psoriatic arthritis, Multiple sclerosis
- NCT number
- NCT04334031
What you commit to
- Study type: Interventional
- Planned participants: 2200
- From 20 Jul 2020 to the primary completion date, 20 Jul 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of coverage by the social security system.
- Pregnant or breastfeeding woman
- Persons deprived of liberty
- Protected minors or adults
- Persons who have refused or are incapable of giving informed consent
- Persons in Emergency Situations
Who the study is looking for
- Patient followed for their IMID in one of the departments of the Lille University Hospital participating in the study (dermatology, internal medicine, neurology, pneumology and rheumatology)
- Social insured
- Have the capacity to understand the study requirements, provide written informed consent, and comply with the study data collection procedures.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hop Claude Huriez Chu Lille Coordinator of this site? Confirm its status | Lille | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.